Information Provided By: 
Fly News Breaks for January 6, 2017
PODD
Jan 6, 2017 | 07:41 EDT
As previously reported, Baird analyst Jeff Johnson upgraded Insulet to Outperform from Neutral. The analyst believes the company's solid U.S. Omnipod momentum leads to a clear path for margin improvement and upside to Street estimates. Johnson raised his price target to $47 from $39 on Insulet shares.
News For PODD From the Last 2 Days
There are no results for your query PODD
